MedElevator Войти в исследования
← Поиск публикаций
Медицинская библиотека · Revista espanola de cardiologia · 2007

[Chronic anemia in heart transplant patients: prevalence, predisposing factors and prognostic significance].

Cursack Guillermo C, Crespo-Leiro María G, Paniagua-Martín María J, Muñiz Javier, Naya Carmen, Grille Zulaika, Rodríguez José A, Marzoa Raquel, Barge Eduardo, Ríos Ramón, Estévez Francisco, Cuenca José J, Juffé-Stein Alberto, Castro-Beiras Alfonso

Аннотация на английскомСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

INTRODUCTION AND

OBJECTIVES

Data on chronic anemia following heart transplantation (HT) are scarce and contradictory. Our aims were to determine the prevalence of chronic anemia after HT, to identify predisposing factors for the condition at 12 months, and to evaluate its influence on medium-term and long-term survival.

METHODS

Retrospective analysis of patients who underwent HT between 1991 and 2005 (n=457). Chronic anemia was defined as a hemoglobin level <12 g/dL.

RESULTS

The prevalence of post-HT chronic anemia was 75.5% at 1 month, 31% at 12 months, and 26.2% at 120 months. The condition was significantly more prevalent among women than men. Predisposing factors for chronic anemia 1 year post-HT were mild-to-moderate chronic renal failure (i.e., creatinine level >1.5 mg/dL; odds ratio [OR]=2.8; 95% confidence interval [CI], 1.5-5.0), female sex (OR=6.4; 95% CI, 3.1-13.2), and immunosuppression with mycophenolate mofetil compared with azathioprine (OR=2.6;, 95% CI, 1.4-4.8). The prevalence of chronic anemia 12 months after HT was independent of the donor's sex, the recipient's age, the etiology of the recipient's heart failure, diabetes mellitus, mild-to-moderate graft rejection, cytomegalovirus infection, and angiotensin-converting enzyme inhibitor treatment. The presence of chronic anemia 12 months after HT did not influence either long-term survival (mean, 11.5 years with chronic anemia vs. 13.0 years without) or actuarial survival.

CONCLUSIONS

Post-HT chronic anemia is common, but improves with time and treatment. Predisposing factors for the condition 1 year post-HT include chronic renal failure, female sex, and immunosuppression with mycophenolate mofetil. The presence of chronic anemia does not appear to influence long-term survival.

Для цитирования: Cursack Guillermo C, Crespo-Leiro María G, Paniagua-Martín María J, Muñiz Javier, Naya Carmen, Grille Zulaika, Rodríguez José A, Marzoa Raquel, Barge Eduardo, Ríos Ramón, Estévez Francisco, Cuenca José J, Juffé-Stein Alberto, Castro-Beiras Alfonso. [Chronic anemia in heart transplant patients: prevalence, predisposing factors and prognostic significance].. Revista espanola de cardiologia. 2007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.